NeurAxis, Inc. entered into a securities purchase agreement for issuance of 1,260,504 series B convertible preferred stock at price of $2.38 per share for gross proceeds of $3,000,000 on November 9, 2023. The transaction will include participation from new investor Flagstaff International, Inc. The aggregate purchase price is to be paid in 15 monthly installments of $200,000 each, commencing on the later of January 10, 2024 or a date after stockholders approve of an amendment to the company?s certificate of incorporation to authorize the creation of the shares. The series B preferred stock is convertible at any time into shares of common stock of the company without any further consideration.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.24 USD | +2.21% | +2.53% | +21.35% |
May. 22 | Earnings Flash (NRXS) NEURAXIS Posts Q1 Revenue $646,635 | MT |
May. 22 | Neuraxis, Inc. Provides Earnings Guidance for Late 2024 and 2025 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+21.35% | 20.91M | |
+75.69% | 12.57B | |
-24.12% | 7.29B | |
+10.90% | 6.81B | |
+20.88% | 5.67B | |
-16.83% | 4.91B | |
+19.43% | 4.18B | |
-19.35% | 3.86B | |
-24.00% | 2.92B | |
+52.88% | 2.57B |
- Stock Market
- Equities
- NRXS Stock
- News NeurAxis, Inc.
- NeurAxis, Inc. announced that it expects to receive $3 million in funding from Flagstaff International, Inc